help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 28, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-1476
This Article
Right arrow Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Horne, A. W.
Right arrow Articles by Critchley, H. O. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horne, A. W.
Right arrow Articles by Critchley, H. O. D.

Submitted on July 13, 2009
Accepted on September 21, 2009

Attenuated Sex Steroid Receptor Expression in Fallopian Tube of Women with Ectopic Pregnancy

Andrew W. Horne, Anne E. King, Edward Shaw, Sarah E. McDonald, Alistair R. W. Williams, Philippa T. Saunders, and Hilary O. D. Critchley*

Divisions of Reproductive and Developmental Sciences (A.W.H., A.E.K., E.S., S.E.M., H.O.D.C.) and Pathology (A.R.W.W.), The University of Edinburgh, and Medical Research Council Human Reproductive Sciences Unit (P.T.S.), Edinburgh EH16 4TJ, United Kingdom

* To whom correspondence should be addressed. E-mail: hilary.critchley{at}ed.ac.uk.

Context: Sex steroid hormone receptor (SHR) dynamics are well-documented in human endometrium but have not been comprehensively studied in Fallopian tube (FT).

Objective: The aim of the study was to compare expression patterns and hormonal regulation of SHR in FT with that described in endometrium and to determine whether SHR expression is altered in FT of women with ectopic pregnancy (EP).

Design: Tissue was analyzed and cultured.

Patients or Other Participants: Women undergoing surgery for benign gynecological conditions (n = 14) and EP (n = 6) participated in the study.

Interventions: Quantitative RT-PCR and immunohistochemistry were used to determine SHR mRNA expression and protein localization, respectively. SHR levels were measured in tubal explant cultures stimulated with estrogen and progestogen.

Results: ER{alpha} and ER{beta} mRNAs were constitutively expressed in FT during the menstrual cycle. PR-AB and PR-B mRNAs were decreased in midluteal phase compared to follicular phase. ER{alpha}, PR-AB, and PR-B mRNAs were down-regulated in human FT in vitro by treatment with progestogen. ER{alpha}, ER{beta}1, ER{beta}2, PR, and AR proteins localized to cell nuclei of epithelium, stroma, and smooth muscle of nonpregnant FT. In FT from women with EP, PR-B mRNA was decreased when compared to midluteal FT, and ER{alpha} protein was not detected.

Conclusions: SHR expression in FT is different from that observed in endometrium recovered at similar stages of the menstrual cycle, and expression in FT from women with EP is also altered compared with normal FT. These data are an important benchmark for furthering the understanding of normal human FT physiology, changes in expression of SHR in FT in response to progesterone, and disorders of FT function, such as EP.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society